Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer
Takehiro Tozuka, Rintaro Noro, Hideaki Mizutani, Futoshi Kurimoto, Taiki Hakozaki, Kakeru Hisakane, Tomoyuki Naito, Satoshi Takahashi, Namiko Taniuchi, Chika Yajima, Yukio Hosomi, Takashi Hirose, Yuji Minegishi, Tetsuya Okano, Koichiro Kamio, Tomoyoshi Yamaguchi, Masahiro Seike
Topics & Concepts
OsimertinibMedicineHazard ratioInternal medicineLung cancerOncologyProgression-free survivalConfidence intervalRetrospective cohort studyCancerChemotherapyEpidermal growth factor receptorErlotinibLung Cancer Treatments and MutationsBrain Metastases and TreatmentLung Cancer Research Studies